British Biotech calls in Fellner to kick start industry consolidation

Peter Fellner, currently chief executive of Celltech, has been appointed chairman of British Biotech and promised to kick start consolidation in the bombed out biotech sector.

He will initially take a non-executive role but is expected to move into an executive post next spring to steer British Biotech into a vital merger.

He unveiled ambitious plans to use the pioneering biotech company as a "nucleus" for a group combining several of the UK's smaller quoted drug developers.

"British Biotech has a strong balance sheet and embedded within the company are groups of high quality people working in clinical development," he said. "I am quite attracted by the idea of using it as a consolidation vehicle.

"It will be a challenge, but the environment for biotech currently is more difficult than I have known since I joined it in 1990, and it looks as if these difficulties will go on longer. That will be a catalyst to consolidation this time."

British Biotech has a £43m cash pile but no products anywhere near launch. Other companies in the sector have more advanced drugs but are burning cash trying to prove they work.

British Biotech reduced its interim losses to £8.1m in the six months to 31 October from £8.4m last year by selling many of its pre-clinical development facilities and cutting costs.

Mr Fellner argued that a string of deals could create a company with critical mass and better able to attract funding from shareholders or product licensees. Investors expressed their enthusiasm by chasing British Biotech shares up 29 per cent to 4.5p.

They peaked at 145p in 1998 but the company's supposed wonder drug for cancer, marimastat, failed to work and a previous management was ousted after claims that it failed to give timely information to shareholders on marimastat's disappointing performance in clinical trials. The company is still being threatened with legal action from lawyers representing some shareholders but no formal proceedings have begun.

Mr Fellner dismissed suggestions this potential liability could scupper his plans to woo merger partners, saying he had taken advice and concluded the claims were groundless. British Biotech said there has been greater interest from other biotech players since the departure, in October, of Elliot Goldstein, its chief executive.

Mr Fellner replaces Christopher Hampson, who retires at the end of the month, but will only move into an executive role when he is able to step back from the chief executive post at Celltech.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Customer Relations Officer

£13000 per annum: Recruitment Genius: This is an exciting opportunity to join ...

Ashdown Group: Junior Application Support Analyst - Fluent German Speaker

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Jemma Gent: Project Coordinator

£12 - £15 Hourly Rate: Jemma Gent: In this role you will report to the Head of...

Recruitment Genius: Evening Administrator

£8 per hour: Recruitment Genius: This Pension Specialist was established early...

Day In a Page

Homeless Veterans campaign: Donations hit record-breaking £1m target after £300,000 gift from Lloyds Bank

Homeless Veterans campaign

Donations hit record-breaking £1m target after huge gift from Lloyds Bank
Flight MH370 a year on: Lost without a trace – but the search goes on

Lost without a trace

But, a year on, the search continues for Flight MH370
Germany's spymasters left red-faced after thieves break into brand new secret service HQ and steal taps

Germany's spy HQ springs a leak

Thieves break into new €1.5bn complex... to steal taps
International Women's Day 2015: Celebrating the whirlwind wit of Simone de Beauvoir

Whirlwind wit of Simone de Beauvoir

Simone de Beauvoir's seminal feminist polemic, 'The Second Sex', has been published in short-form for International Women's Day
Mark Zuckerberg’s hiring policy might suit him – but it wouldn’t work for me

Mark Zuckerberg’s hiring policy might suit him – but it wouldn’t work for me

Why would I want to employ someone I’d be happy to have as my boss, asks Simon Kelner
Confessions of a planespotter: With three Britons under arrest in the UAE, the perils have never been more apparent

Confessions of a planespotter

With three Britons under arrest in the UAE, the perils have never been more apparent. Sam Masters explains the appeal
Russia's gulag museum 'makes no mention' of Stalin's atrocities

Russia's gulag museum

Ministry of Culture-run site 'makes no mention' of Stalin's atrocities
The big fresh food con: Alarming truth behind the chocolate muffin that won't decay

The big fresh food con

Joanna Blythman reveals the alarming truth behind the chocolate muffin that won't decay
Virginia Ironside was my landlady: What is it like to live with an agony aunt on call 24/7?

Virginia Ironside was my landlady

Tim Willis reveals what it's like to live with an agony aunt on call 24/7
Paris Fashion Week 2015: The wit and wisdom of Manish Arora's exercise in high camp

Paris Fashion Week 2015

The wit and wisdom of Manish Arora's exercise in high camp
8 best workout DVDs

8 best workout DVDs

If your 'New Year new you' regime hasn’t lasted beyond February, why not try working out from home?
Paul Scholes column: I don't believe Jonny Evans was spitting at Papiss Cissé. It was a reflex. But what the Newcastle striker did next was horrible

Paul Scholes column

I don't believe Evans was spitting at Cissé. It was a reflex. But what the Newcastle striker did next was horrible
Miguel Layun interview: From the Azteca to Vicarage Road with a million followers

From the Azteca to Vicarage Road with a million followers

Miguel Layun is a star in Mexico where he was criticised for leaving to join Watford. But he says he sees the bigger picture
Frank Warren column: Amir Khan ready to meet winner of Floyd Mayweather v Manny Pacquiao

Khan ready to meet winner of Mayweather v Pacquiao

The Bolton fighter is unlikely to take on Kell Brook with two superstar opponents on the horizon, says Frank Warren
War with Isis: Iraq's government fights to win back Tikrit from militants - but then what?

Baghdad fights to win back Tikrit from Isis – but then what?

Patrick Cockburn reports from Kirkuk on a conflict which sectarianism has made intractable